Sandy Close

Sandra Close Ph.D. is the Chief Operations Officer of Foresight Diagnostics. Sandy has extensive experience in delivering drugs and diagnostics to market, with a focus on organizational structure, business strategy, and quality and regulatory requirements.Prior to joining Foresight, Sandy served as Chief Diagnostic Strategy Officer at ArcherDX/Invitae where she led efforts to advance an NGS-based molecular diagnostic platform for genetic mutation detection, including MRD products.Dr. Close also served as Chief of Integrative Science & Collaborative Research for BioStatistics Solutions, Inc., Chief Scientific Officer at Arrogen, and as a Research Advisor at Ph.D Eli Lilly & Company. Sandy received her Ph.D. in Medical and Molecular Genetics from Indiana University-Indianapolis, M.S. from Columbia University in the City of New York, and B.S. from Indiana University-Bloomington.